Isabel Blancas - Concepedia

Author

Isabel Blancas

Instituto de Investigación Biosanitaria de Granada ORCID

Also Known As

C. Llorca, I. B. López-Barajas, I. Blancas, I. Blancas López-Barajas, ISABEL BLANCAS, Isabel B. López-Barajas, Isabel Blancas, Isabel Blancas Lopez-Barajas, Isabel Blancas López-Barajas, María Isabel Blancas López-Barajas

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Instituto de Investigación Biosanitaria de Granada Vall d'Hebron Hospital Universitari Institut Català d'Oncologia Universidad de Granada Fundación Hospital Provincial de Castellón

About

Isabel Blancas is an author at Instituto de Investigación Biosanitaria de Granada specializing in oncology, medicine, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	117
2	Health Sciences	2	2	70
3	Pathology	2	2	72
4	Cell Biology	1	1	21
5	Immunology	1	1	49

Isabel Blancas

Publications

729

Citations

H-Index

Page 1

	Year	Citations
Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer Juan Miguel Cejalvo, Eduardo Martínez de Dueñas, Patricia Galván, Cancer Research	2017	239
GEMOX‐R regimen is a highly effective salvage regimen in patients with refractory/relapsing diffuse large‐cell lymphoma: a phase II study Andrés López, Antonio Gutiérrez, Andrés Palacios, European Journal Of Haematology	2007	110
Prospective evaluation of the conversion rate in the receptor status between primary breast cancer and metastasis: results from the GEICAM 2009-03 ConvertHER study Eduardo Martínez de Dueñas, Ana Lluch Hernández, Ángel Guerrero Zotano, Breast Cancer Research and Treatment	2014	65
Adjusting the dose of tamoxifen in patients with early breast cancer and CYP2D6 poor metabolizer phenotype Eduardo Martínez de Dueñas, Enrique Ochoa Aranda, Isabel Blancas, The Breast	2014	53
Rituximab, gemcitabine and oxaliplatin: An effective regimen in patients with refractory and relapsing mantle cell lymphoma José Rodríguez, Antonio Gutiérrez, Andrés Palacios, Leukemia & lymphoma/Leukemia and lymphoma Hematological MalignancyLymphoid NeoplasiaAdvanced AgeMantle Cell LymphomaMedicine	2007	49
Influence of CYP2D6 Polymorphisms on Serum Levels of Tamoxifen Metabolites in Spanish Women with Breast Cancer Mercedes Zafra-Ceres, Tomás de Haro, Esther Farez-Vidal, International Journal of Medical Sciences	2013	31
NT-proBNP as predictor factor of cardiotoxicity during trastuzumab treatment in breast cancer patients Isabel Blancas, Francisco Javier Martín-Pérez, José Manuel Garrido, The Breast	2020	25
Low number of examined lymph nodes in node-negative breast cancer patients is an adverse prognostic factor Isabel Blancas, José L. García-Puche, Begoña Bermejo, Annals of Oncology Breast OncologyMedicinePathologyBreast ImagingBreast Cancer	2006	23
SEOM–GEICAM–SOLTI clinical guidelines in advanced breast cancer (2022) José Á. García-Sáenz, Isabel Blancas, Isabel Echavarría, Clinical & Translational Oncology	2023	23
Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis Manuel Cobo, C. Beato Zambrano, Luis Cabezón Gutiérrez, BMJ Supportive & Palliative Care	2020	22

Page 1